In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension

J Infect. 2020 Nov;81(5):816-846. doi: 10.1016/j.jinf.2020.08.014. Epub 2020 Aug 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists* / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Hypertension* / drug therapy
  • Hypertension* / epidemiology
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors